Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

China flag China · Delayed Price · Currency is CNY
16.89
-0.01 (-0.06%)
Apr 30, 2026, 2:04 PM CST
Market Cap3.71B -8.0%
Revenue (ttm)265.08M -24.3%
Net Income-16.46M
EPS-0.07
Shares Out219.47M
PE Ration/a
Forward PEn/a
Dividend1.20 (6.83%)
Ex-Dividend DateJun 12, 2025
Volume2,569,151
Average Volume6,746,469
Open16.92
Previous Close16.90
Day's Range16.77 - 17.00
52-Week Range15.28 - 23.28
Beta0.41
RSI47.65
Earnings DateApr 21, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China. [Read more]

Sector Healthcare
Founded 2008
Employees 812
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002932
Full Company Profile

Financial Performance

Financial Statements